Trial Projects

Transatlantic, multi-center, placebo-controlled, randomized, double-blind clinical trial to demonstrate that transdermal nicotine treatment retards parkinson's disease progression as measured by change in total (part I, II, III) UPDRS score between baseline and after 52 weeks of study treatment plus two more months wash out (60 weeks).

Clinical trial to o evaluate the efficacy of AOP2014 in a randomized phase III, multicenter setting with post-study follow-up

Clinical study to compare overall survival (OS) in patients with platinumsensitive recurrent ovarian cancer with a positive AGO-score randomized to tumor debulking surgery followed by chemotherapy of physician’s choice versus chemotherapy of physician’s choice alone

Aim of the study is to investigate if adjuvant immunoadsorption is superior to standard immunosuppressive treatment in inducing clinical remission in pemphigus.

Clinical study to assess the efficacy of systematic pelvic and para-aortic lymphadenectomy in patients with advanced ovarian cancer and intra-abdominal complete debulking.

A randomized, placebo-controlled, double-blind, parallel group, multi-center, phase III trial to address treatment options for combined post- and pre-capillary pulmonary hypertension and heart failure with preserved ejection fraction